soul trial oral semaglutide cardiovascular outcomes soul trial results Canadian Perspectives 2025 Whiteboard on the Oral Semaglutide Cuts Cardiovascular Risk

For researchers transitioning from tirzepatide, the retatrutide dosage schedule after high-dose tirzepatide provides specific guidance on bridging between compounds

Zepbound (tirzepatide) is currently the most effective medication available for weight management

Most filings to date have originated in New Jersey federal court, where plaintiffs propose the new MDL should be centralized

Patients who continue with treatment and implement recommended lifestyle adjustments can achieve considerable weight loss over a period of 6 to 12 months or more

What this means in practice for the optimization-focused research community: triple agonism appears to add a distinct energy expenditure component on top of the appetite suppression and enhanced insulin signaling already established by dual agonism